MICHAEL BEST STRATEGIES LLC

Lobbying for SAREPTA THERAPEUTICS · Medical research and drug development company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $40,000.00 income · posted Jul 21, 2025

Lobbying activity 2

Health Issues

Rare disease therapeutic development and access

Medical/Disease Research/Clinical Labs

Rare disease therapeutic development and access

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.